John S. Yu, MD
4.9
21 Reviews
310-423-7900
Fax: 310-967-8592
4.9
21 Reviews
John S. Yu, MD
Scheduling
In person visits
Fax: 310-967-8592
Neurosurgery - Pavilion
127 S San Vicente Blvd #A6600
Los Angeles, CA
34.074522 -118.379067From You
4.9
21 Reviews
John S. Yu, MD
Languages
- English,
- French,
- Korean,
Gender
Male
Experience
32 Years
Locations
Experience
Specialties
Area in which a healthcare provider is highly trained and often board certified.
1
- Neurosurgery
Programs
Cedars-Sinai clinical programs this provider is part of:
4
Research Areas
The research of John S. Yu, MD, focuses on immune and stem cell therapy for brain tumors, cancer stem cells and their microenvironment in brain tumors. Dr. Yu also researches cancer stem cell-specific cytotoxic T lymphocytes, cancer stem cell signaling, mechanism of cancer invasion, cancer stem cell-specific cytotoxic T lymphocytes, targeted immunochemotherapy using nanotechnology, and development of imaging and diagnostic agents using nanoparticles.
Titles
- Director, Surgical Neuro-Oncology
- Vice Chair, Neurosurgical Oncology in the Department of Neurosurgery
- Professor, Neurosurgery
Education & Training
-
Massachusetts General Hospital
Residency - Completed 1997
-
Harvard-MIT Division of Health Sciences and Technology
Degrees - Completed 1990
-
Harvard Medical School
Medical School - Completed 1990
-
National Institute of Mental Health
Fellowship - Completed 1989
-
Stanford University
Degrees - Completed 1985
Achievements
-
1
Board Certifications
-
7
Awards and Honors
-
4
Publications
Board Certifications
-
Neurosurgery
American Board of Neurological Surgery
Awards and Honors
- Mahaley Clinical Research Award, American Association of Neurological Surgeons and Congress of Neurological Surgeons
- America's Top Cancer Specialists, Newsweek
- Academy Award, American Academy of Neurological Surgery
- America'a Top Doctors, Castle and Connolly
- Preuss Award, Joint Section on Tumors, American Association of Neurological Surgeons and Congress of Neurological Surgeons
- Southern California Super Doctors, Los Angeles Magazine
- Culpeper Scholar, Molecular Neurogenenics, Massachusetts General Hospital
Publications
A full list of this provider’s research publications can be found on their research profile or PubMed.
- Xu Q, Liu G, Yuan X, Xu M, Wang H, Ji J, Konda B, Black KL, Yu JS. Antigen-specific T cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens. Stem Cells. 2009;27(8):1734-1740.
- Ji J, Judkowski VA, Liu G, Wang H, Bunying A, Li Z, Xu M, Bender J, Pinilla C, Yu JS. Identification of novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitopes on CD133 for cancer stem cell immunotherapy. Stem Cells Transl Med. 2014;3(3):356-364.
- Lee BS, Amano T, Wang HQ, Pantoja JL, Yoon CW, Hanson CJ, Amatya R, Yen A, Black KL, Yu JS. Reactive oxygen species responsive nanoprodrug to treat intracranial glioblastoma. ACS Nano. 2013;7(4):3061-3077.
- Phuphanich S, Wheeler CJ, Rudnick JD, Mazer M, Wang HQ, Nuno MA, Richardson JE, Fan X, Ji J, Chu RM, Bender JM, Hawkins ES, Patil CG, Black KL, Yu JS. Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma. Cancer Immunol Immunother. 2013;62(1):125-135.